abstract |
The present disclosure provides methods of screening, diagnosing, monitoring and/or treating acid sphingomyelinase (ASM) disorders, such as Niemann-Pick's disease. In particular, the methods include improved diagnostic and/or therapeutic techniques for ASM disorders, for example using enzyme replacement therapy. |